STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital is among the first in the country to successfully treat ...

The upper pulmonary veins (PVs) are responsible for the majority of atrial fibrillation (AF) triggering foci, whereas the inferior PVs are more difficult to ablate and prone to postablation ostial ...

A new all-in-one pulsed field ablation catheter system demonstrated durable pulmonary vein isolation and a promising safety ...

The study subjects were 51 consecutive patients with highly symptomatic permanent (n = 25) or persistent (n = 26) atrial fibrillation resistant to, or intolerant of, drug therapy. Atrial ...

Rivaroxaban tablets have several indications, including reducing the risk of stroke and systemic embolism in nonvalvular ...

Bangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval for its Abbreviated New ...

A study was conducted to determine sex differences in ablation strategy and outcomes in patients with paroxysmal atrial fibrillation receiving radiofrequency ablation.

Biocon said that its subsidiary Biocon Pharma has received approval for its ANDA for Rivaroxaban Tablets USP from the United States Food and Drug Administration (US FDA), for various strengths.

Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lup ...

Tom Nolan reviews this week’s research There’s certainly a gap in the market for an effective third or fourth line antihypertensive. A trial of lorundrostat, an aldosterone synthase inhibitor, found a ...

Drugmaker Lupin has received U.S. Food and Drug Administration (U.S. FDA) approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, its generic version of Janssen Pharmaceuticals’ blood thinner ...